Apogepha Arzneimittel GmbH

Apogepha Arzneimittel GmbH is a Gesellschaft mit beschränkter Haftung registered in Dresden, Germany and holds an LEI in its own name.

The LEI has been on record for 11 years, since 21 Jan 2015. That is about 5 years earlier than the median LEI in Germany, which dates from 2019 — an early adopter by local standards.

Annual re-validation is 2824 days overdue: it fell due 10 Nov 2018. An LEI that is not re-validated lapses, which does not invalidate it but marks the reference data as unverified.

The record has not changed since we began archiving it on 6 Jul 2026. Any future change to name, status, address, ownership or renewal date will be captured here, because GLEIF publishes only the current state and superseded values are otherwise lost.

The entity is registered with Commercial Register under registry number HRB 515, and the LEI itself is issued and maintained by Herausgebergemeinschaft Wertpapier-Mitteilungen Keppler, Lehmann GmbH & Co. KG, one of the Local Operating Units accredited by GLEIF.

No direct accounting-consolidating parent is reported, because no controlling person is known. GLEIF requires this to be stated explicitly rather than left blank, so the absence is itself a data point.

No ultimate accounting-consolidating parent is reported, because no controlling person is known. GLEIF requires this to be stated explicitly rather than left blank, so the absence is itself a data point.

The LEI registration is lapsed, and the entity status (active) records whether the legal entity itself still exists. The two are independent: an LEI can lapse while the company trades on, and it can stay issued after the company has been dissolved.